{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:02:45Z","timestamp":1793505765680,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejpb.2024.114622","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T16:04:37Z","timestamp":1735142677000},"page":"114622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions"],"prefix":"10.1016","volume":"207","author":[{"given":"Pauline","family":"Claraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Fillaudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Storme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Guillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"White-Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Puisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114622_b0005","unstructured":"EMA. European Medicines Agency. 10\u2010year Report to the European Commission: General report on the experience acquired as a result of the application of the Paediatric Regulation (EMA\/231225\/2015) [Internet]. 2016 [cited 2024 Dec 11]. Available from: https:\/\/health.ec.europa.eu\/system\/files\/2017-11\/2017_childrensmedicines_report_en_0.pdf."},{"key":"10.1016\/j.ejpb.2024.114622_b0010","unstructured":"Committee for Medicinal Products for Human Use (CHMP), EMA. Guideline on pharmaceutical development of medicines for paediatric use [Internet]. 2013 [cited 2024 Dec 11]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf."},{"issue":"657","key":"10.1016\/j.ejpb.2024.114622_b0015","article-title":"Exploring paediatric oral suspension development: Challenges, requirements, and formulation advancements","volume":"25","author":"Gaikwad","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114622_b0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0731-7085(02)00252-2","article-title":"Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide","volume":"30","author":"Mura","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114622_b0025","first-page":"1","article-title":"A review on pharmaceutical suspension and its advancement","volume":"25","author":"Arora","year":"2022","journal-title":"Ann. Clin. Case. Rep."},{"key":"10.1016\/j.ejpb.2024.114622_b0030","unstructured":"Brochure_InOrpha_Ora_09.2022.pdf [Internet]. [cited 2024 Jun 10]. Available from: https:\/\/www.inresa.fr\/wp-content\/uploads\/2023\/02\/Brochure_InOrpha_Ora_09.2022.pdf."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114622_b0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s004550011003","article-title":"Effect of liquid bolus consistency and delivery method on aspiration and pharyngeal retention in dysphagia patients","volume":"16","author":"Kuhlemeier","year":"2001","journal-title":"Dysphagia."},{"key":"10.1016\/j.ejpb.2024.114622_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biotri.2019.02.002","article-title":"Gellan gum: A new member in the dysphagia thickener family","volume":"17","author":"Torres","year":"2019","journal-title":"Biotribology."},{"key":"10.1016\/j.ejpb.2024.114622_b0045","doi-asserted-by":"crossref","unstructured":"Sworn G. Chapter 9 - Gellan gum. In: Phillips GO, Williams PA, editors. Handbook of Hydrocolloids (Second Edition). 200p. 204\u201327.","DOI":"10.1533\/9781845695873.204"},{"issue":"311","key":"10.1016\/j.ejpb.2024.114622_b0050","article-title":"Progress and opportunities in Gellan gum-based materials: A review of preparation, characterization and emerging applications","volume":"1","author":"Gomes","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114622_b0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2014.03.038","article-title":"Application of gellan gum in pharmacy and medicine","volume":"466","author":"Osma\u0142ek","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114622_b0060","series-title":"Microbial Polymers: Applications and Ecological Perspectives","first-page":"87","article-title":"A Review on Properties and Applications of Xanthan Gum","author":"Chaturvedi","year":"2021"},{"issue":"216","key":"10.1016\/j.ejpb.2024.114622_b0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.189","article-title":"Xanthan gum in aqueous solutions: Fundamentals and applications","volume":"1","author":"Nsengiyumva","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114622_b0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcab.2017.02.013","article-title":"Effective variables on production and structure of xanthan gum and its food applications: A review","volume":"1","author":"Habibi","year":"2017","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"10.1016\/j.ejpb.2024.114622_b0075","doi-asserted-by":"crossref","unstructured":"Sworn G. Chapter 27 - Xanthan gum. In: Phillips GO, Williams PA, editors. Handbook of Hydrocolloids (Third Edition). 2021. p. 833\u201353.","DOI":"10.1016\/B978-0-12-820104-6.00004-8"},{"issue":"2","key":"10.1016\/j.ejpb.2024.114622_b0080","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.carbpol.2013.01.030","article-title":"An insight into the emerging exopolysaccharide gellan gum as a novel polymer","volume":"93","author":"Prajapati","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2024.114622_b0085","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - INEXIUM 10 mg, granul\u00e9s gastro-r\u00e9sistants pour suspension buvable en sachet - Base de donn\u00e9es publique des m\u00e9dicaments [Internet]. [cited 2024 Sep 6]. Available from: https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=63451237&typedoc=R."},{"key":"10.1016\/j.ejpb.2024.114622_b0090","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - DOLIPRANE 2,4 POUR CENT, suspension buvable - Base de donn\u00e9es publique des m\u00e9dicaments [Internet]. [cited 2024 Sep 6]. Available from: https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=66477582&typedoc=R."},{"key":"10.1016\/j.ejpb.2024.114622_b0095","unstructured":"Phillips GO, Williams PA. Handbook of Hydrocolloids. 2nd ed. Elsevier; 2009. 949 p. (Woodhead Publishing Series in Food Science, Technology and Nutrition)."},{"issue":"79","key":"10.1016\/j.ejpb.2024.114622_b0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.foodhyd.2017.12.035","article-title":"Sensory characteristics of liquids thickened with commercial thickeners to levels specified in the International Dysphagia Diet Standardization Initiative (IDDSI) framework","volume":"1","author":"Ong","year":"2018","journal-title":"Food. Hydrocoll."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114622_b0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00455-012-9412-2","article-title":"Promoting Safe Swallowing When Puree is Swallowed Without Aspiration but Thin Liquid is Aspirated: Nectar is Enough","volume":"28","author":"Leder","year":"2013","journal-title":"Dysphagia."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114622_b0110","article-title":"Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg\/ml ursodeoxycholic acid for newborns. Pharm Technol","volume":"5","author":"Hausherr","year":"2020","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.ejpb.2024.114622_b0115","unstructured":"Baillieu V, Claraz P, Sanchez C, Benakouche S, Le Liboux J, Vasseur V, et al. Formulation et \u00e9valuation de la stabilit\u00e9 physico-chimique d\u2019une suspension buvable d\u2019allopurinol 20mg\/mL [Internet]. [cited 2024 May 29]. Available from: https:\/\/www.gerpac.eu\/formulation-et-evaluation-de-la-stabilite-physico-chimique-d-une-suspension-buvable-d-allopurinol-20mg-ml."},{"key":"10.1016\/j.ejpb.2024.114622_b0120","unstructured":"Desquines R, Ramjaun Z, Jurado C. Optimisation d\u2019une formulation de suspension buvable de Spironolactone \u00e0 5mg\/ml pour les nourrissons, assortie de son \u00e9tude de stabilit\u00e9 [Internet]. [cited 2024 May 29]. Available from: https:\/\/www.gerpac.eu\/optimisation-d-une-formulation-de-suspension-buvable-de-spironolactone-a-5mg-ml-pour-les-nourrissons-assortie-de-son-etude-de-stabilite."},{"issue":"160","key":"10.1016\/j.ejpb.2024.114622_b0125","article-title":"Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children","volume":"1","author":"Fuss","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114622_b0130","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/0885328218762361","article-title":"Rheological investigation of high-acyl gellan gum hydrogel and its mixtures with simulated body fluids","volume":"32","author":"Osma\u0142ek","year":"2018","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ejpb.2024.114622_b0135","first-page":"5","article-title":"Pharmaceutical suspensions\u00a0: patient compliance oral dosage forms","volume":"1","author":"Yagnesh","year":"2016","journal-title":"World. J. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114622_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2009.02.013","article-title":"Thixotropic property in pharmaceutical formulations","volume":"136","author":"Lee","year":"2009","journal-title":"J. Controlled. Release."},{"key":"10.1016\/j.ejpb.2024.114622_b0145","series-title":"Pharmaceutical Dosage Forms","article-title":"Viscosity-Imparting Agents in Disperse Systems","author":"Zatz","year":"1996"},{"key":"10.1016\/j.ejpb.2024.114622_b0150","unstructured":"EMA. Annex to the European Commission guideline on \u2018Excipients in the labelling and package leaflet of medicinal products for human use\u2019 (SANTE-2017-11668) [Internet]. 2019 [cited 2024 Dec 11]. Available from: https:\/\/www.ema.europa.eu\/en\/annex-european-commission-guideline-excipients-labelling-package-leaflet-medicinal-products-human-use."},{"key":"10.1016\/j.ejpb.2024.114622_b0155","unstructured":"EUPFI - Basic Search [Internet]. [cited 2024 Sep 6]. Available from: https:\/\/step-db.ucl.ac.uk\/eupfi\/login.do?flag4Login=loginFlag."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114622_b0160","first-page":"e04909","article-title":"Re-evaluation of xanthan gum (E 415) as a food additive","volume":"15","author":"Mortensen","year":"2017","journal-title":"EFSA. J."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114622_b0165","first-page":"e05296","article-title":"Re\u2010evaluation of gellan gum (E418) as food additive","volume":"16","author":"Younes","year":"2018","journal-title":"EFSA. J."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114622_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/pharmaceutics16010119","article-title":"Potentially harmful excipients: state of the art for oral liquid forms used in neonatology and pediatrics units","volume":"16","author":"Bobillot","year":"2024","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114622_b0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1475-2891-12-54","article-title":"Thickening agents used for dysphagia management: effect on bioavailability of water, medication and feelings of satiety","volume":"12","author":"Cichero","year":"2013","journal-title":"Nutr. J."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114622_b0180","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jada.2007.04.011","article-title":"Comparison of the rheological properties of ready-to-serve and powdered instant food\u2013thickened beverages at different temperatures for dysphagic patients","volume":"107","author":"Adeleye","year":"2007","journal-title":"J. Am. Diet. Assoc."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114622_b0185","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3109\/03639045.2016.1151033","article-title":"Oral medication delivery in impaired swallowing: thickening liquid medications for safe swallowing alters dissolution characteristics","volume":"42","author":"Manrique","year":"2016","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114622_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115430","article-title":"Gellan gum-based delivery systems of therapeutic agents and cells","volume":"229","author":"Palumbo","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114622_b0195","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0168-3659(99)00084-X","article-title":"In situ-gelling gellan formulations as vehicles for oral drug delivery","volume":"60","author":"Miyazaki","year":"1999","journal-title":"J. Controlled. Release."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400448X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400448X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:43:37Z","timestamp":1738439017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112400448X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":39,"alternative-id":["S093964112400448X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114622","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114622"}}